The Welander E384K TIA1 mutation dedifferentiates human insulin-producing cells by upregulating MYC, an effect prevented by the GLP-1R agonist liraglutide

The Welander E384K TIA1 mutation dedifferentiates human insulin-producing cells by upregulating MYC, an effect prevented by the GLP-1R agonist liraglutide

Posted by Svenska Läkaresällskapet on September 22, 2026

-------- Original Version -----------

Svenska Läkaresällskapet belönar artikeln “The Welander E384K TIA1 mutation dedifferentiates human insulin-producing cells by upregulating MYC, an effect prevented by the GLP-1R agonist liraglutide” med Regnells pris 2026.

-------- English Version ------------

The Swedish Medical Society awards the article “The Welander E384K TIA1 mutation dedifferentiates human insulin-producing cells by upregulating MYC, an effect prevented by the GLP-1R agonist liraglutide” with the Regnell Prize 2026

-------- Link if available ----------

No Link available